In the world of health care innovation, speed matters. But when it comes to developing and deploying cutting-edge treatments and therapeutics safely, a cautious and methodical approach is vital as well. Safety matters as much as speed, but faster doesn’t always mean riskier. In her latest blog, AMCP CEO Susan Cantrell discusses the history of the Pre-approval Information Exchange (PIE) Act and how it will help patients.
In this guest blog post, Jennifer Graff, PharmD , discusses incorporating value in coverage decisions and how this applies to AMCP's efforts in addressing value and access.
In 2016, AMCP made pre-approval information exchange (PIE) a legislative priority recognizing its vital importance to patients. On June 8, 2022, the U.S. House of Representatives passed the PIE Act of 2022. Learn more about PIE as a legislative priority for AMCP.
On Nov. 9, 2022, Cliff Goodman, PhD, moderated the AMCP Summit on value-based arrangements. He provides his key takeaways from the virtual event in the latest guest blog.
By Cliff Goodman, PhD, AMCP Summit Moderator, The Lewin Group • 1/4/23
With Congress back to work after the midterm elections, AMCP remains focused on the critical window that remains to pass important pieces of health legislation this year. In this blog post, AMCP CEO Susan Cantrell provides an exciting update on our legislative priority, the Pre-Approval Information Exchange (PIE) Act.
